A Practical Guide to the Use of Mirikizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Practical Guide to the Use of Mirikizumab

Published:2023-10-19 Issue: Volume: Page:
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Barnes Edward L.¹²³

Affiliation:

1. Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA;

2. University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA;

3. Multidisciplinary Center for Inflammatory Bowel Diseases, University of North Carolina, Chapel Hill, North Carolina, USA.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference18 articles.

1. Efficacy and safety of mirikizumab in a randomized phase 2 study of patients with ulcerative colitis;Sandborn;Gastroenterology,2020

2. Incorporating patient experience into drug development for ulcerative colitis: Development of the urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adults;Dubinsky;J Patient Rep Outcomes,2022

3. Mirikizumab as induction and maintenance therapy for ulcerative colitis;D'Haens;N Engl J Med,2023

4. OP26. Efficacy and safety of mirikizumab as induction therapy in patients with moderately to severely active ulcerative colitis: Results from the phase 3 LUCENT-1 study;D'Haens;J Crohns Colitis,2022

5. Efficacy and safety of mirikizumab as maintenance therapy in patients with moderately to severely active ulcerative colitis: Results from the phase 3 LUCENT-2 study;Dubinsky;Gastroenterology,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP